Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Thursday, March 28, 2024 | Back issues
Courthouse News Service Courthouse News Service

Pharmaceuticals

Pharmaceutical company Incyte will pay $12.6 million to resolve allegations it violated the False Claims Act, the Justice Department announced Tuesday, adding that there has been no determination of liability. The company was accused of using an independent foundation to pay copays of certain people taking its drug Jakafi, which has been approved to treat a type of bone marrow cancer.

PHILADELPHIA — Pharmaceutical company Incyte will pay $12.6 million in a settlement to resolve allegations it violated the False Claims Act, the Justice Department announced Tuesday, adding that there has been no determination of liability. The company was accused of using an independent foundation to pay copays of certain people taking its drug Jakafi, which has been approved to treat a type of bone marrow cancer.

Categories / Business, Government, Health

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...